| Application no. and date | 14723716.8 (espacenet) (Federated) (European Patent Register), 20140509 | | Patent/reg. no. and date | DK/EP 3003289, 20190220 | | Publication date | 20160413 | | Priority no. and date | EP 13002762, 20130528, EP 13005748, 20131210, EP 13005745, 20131210 | | EP pub. no. and date |
EP 3003289 20160413 | | Effective date | | | Applicant/owner | Morphochem GmbH, Gmunder Strasse 37-37a
81379 München, DE | | Applicant ref. no. | P68320DK01 | | Inventor | KAPSNER, Thomas, Grasslfinger Str. 7B
82194 Gröbenzell, DE,
DALHOFF, Axel, Obere Bergerheide 40
42113 Wuppertal, DE,
GRAMATTE, Thomas, Goetheallee 28a
01309 Dresden, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/4375 (2006.01) , A61K 31/4709 (2006.01) , A61P 31/04 (2006.01) | | Title | INDGIVELSE AF ANTIBAKTERIELE OXAZOLIDINON-QUINOLON-HYBRID-MIDLER | | Int. application no. | EP2014001253 | | Int. publication no. | WO2014191075 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
